BPC-157 and Apixaban Interaction: Safety, Risks, and Clinical Guidance At a glance Interaction type / pharmacodynamic (bleeding-risk overlap) with theoretical pharmacokinetic uncertainty Human interaction data / none published as of May 2026 BPC-157 FDA status / not FDA-approved
Direct Glutathione Evidence The Antioxidants review specifically noted that "decreased glutathione levels appear to be a distinctive parameter related to the activation and development of oxidative stress in Hashimoto's thyroiditis" and that "several studies have investigated the use of antioxidants in the treatment of Hashimoto's disease, including vitamins C and E, selenium, and glutathione." Animal studies and in vitro research have consistently shown that restoring glutathione levels in thyroid cells reduces oxidative damage, decreases inflammatory cytokine production, and protects against autoantigen formation
Your wellness journey doesn't stop at the injection
You might not experience the same results as you do with standard GLP-1 medications
It has demonstrated positive treatment outcomes for GI tract issues, periodontitis, and lesions of the liver and pancreas
